Breast cancer is a heterogeneous disease, which is the consequence of several genetic and environmental factors. Also, it is one of the most common causes of cancer death and …
The major challenge in the therapeutic applicability of oligonucleotide-based drugs is the development of efficient and safe delivery systems. The carriers should be non-toxic and …
B Gurav, G Srinivasan - Current Science, 2017 - JSTOR
Antisense oligonucleotides are novel, highly selective inhibitors or modulators of gene expression. Attention is now being paid for the use of these agents not only in the treatment …
Objective (s): The use of antisense oligonucleotides (AOs) to restore normal splicing by blocking the recognition of aberrant splice sites by the spliceosome represents an innovative …
S Prasad, A Srivastava, N Singh, H Singh… - … Approaches for Novel …, 2022 - Elsevier
Currently, various computational methods are being used for the purpose of therapeutic design. The advent of the Coronavirus disease-2019 (COVID-19) pandemic has created a …
AK Netam, J Prasad, T Satapathy - 2018 - wjpr.s3.ap-south-1.amazonaws.com
WORLD JOURNAL OF PHARMACEUTICAL RESEARCH Page 1 www.wjpr.net Vol 7, Issue 9, 2018. 26 Netam et al. World Journal of Pharmaceutical Research POTENTIAL ROLE OF …
[引用][C]Delivery of survivin siRNA into breast cancer cell line using new synthetic nanoparticles and determination of the anticancer activity of the nanoplexes